029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD1002a膀胱癌及癌旁组织组合芯片,附TNM和病理分级,50例/100点
点 数100例 数50
行 数10列 数10
点直径(mm)1厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD1002a
 
膀胱癌及癌旁组织微阵列芯片,包含40例癌(35例尿路上皮癌,4例鳞状细胞癌,1例腺癌),+10例癌旁膀胱组织,一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
AT (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIB)
TISSUE  ARRAYS UBD1002a
1
2
3
4
5
6
7
8
9
10
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
I
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
J
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A2251MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A3359FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A4479FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
A5545FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A6672MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A7751MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A8859FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A9979FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
A101045FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
B11177MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B21272MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B31342MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
B41471MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B51550MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
B61677MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B71772MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B81842MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
B91971MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B102050MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
C12138MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
C22248MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C32373FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C42471MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
C52545FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
C62638MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
C72748MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C82873FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C92971MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
C103045FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
D13152MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D23269MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D33360MBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant3*2*2N
D43435MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
D53565MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
D63652MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D73769MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D83860MBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant3*2*2N
D93935MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
D104065MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
E14170MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
E24244MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E34370MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
E44442MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E54572MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
E64670MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant6*5*3N
E74744MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E84870MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
E94942MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E105072MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
F15167MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
F25256MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F35353MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant5*4*2N
F45433MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F55565FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant4*3*2N
F65667MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant4*3*3N
F75756MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F85853MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant5*4*2N
F95933MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F106065FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant4*3*2N
G16137FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
G26245FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
G36355MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
G46425FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
G56570FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
G66637FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
G76745FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
G86855MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
G96925FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
G107070FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
H17146MBladderSquamous cell carcinoma*T2aN0M0IIMalignant*N
H27253MBladderSquamous cell carcinoma*T2N0M0IIMalignant4.5*4.5*3N
H37367MBladderSquamous cell carcinoma*T3aN0M0IIIAMalignant4*4*3.5N
H47457MBladderSquamous cell carcinoma*T3aN0M0IIIAMalignant*N
H57546FBladderAdenocarcinoma*T3bN2M0IIIBMalignant*N
H67646MBladderSquamous cell carcinoma*T2aN0M0IIMalignant*N
H77753MBladderSquamous cell carcinoma*T2N0M0IIMalignant4.5*4.5*3N
H87867MBladderSquamous cell carcinoma*T3aN0M0IIIAMalignant4*4*3.5N
H97957MBladderSquamous cell carcinoma*T3aN0M0IIIAMalignant*N
H108046FBladderAdenocarcinoma*T3bN2M0IIIBMalignant*N
I18154MBladderCancer adjacent bladder tissue***AT*N
I28278FBladderCancer adjacent bladder tissue***AT*N
I38358MBladderCancer adjacent bladder tissue***AT*N
I48468MBladderCancer adjacent bladder tissue***AT*N
I58573MBladderCancer adjacent bladder tissue***AT*N
I68654MBladderCancer adjacent bladder tissue***AT*N
I78778FBladderCancer adjacent bladder tissue***AT*N
I88858MBladderCancer adjacent bladder tissue***AT*N
I98968MBladderCancer adjacent bladder tissue***AT*N
I109073MBladderCancer adjacent bladder tissue***AT*N
J19175MBladderCancer adjacent bladder tissue***AT*N
J29265MBladderCancer adjacent bladder tissue***AT*N
J39350FBladderCancer adjacent bladder tissue***AT*N
J49453MBladderCancer adjacent bladder tissue***AT*N
J59553MBladderCancer adjacent bladder tissue with squamous metaplasia***AT*N
J69675MBladderCancer adjacent bladder tissue***AT*N
J79765MBladderCancer adjacent bladder tissue***AT*N
J89850FBladderCancer adjacent bladder tissue***AT*N
J99953MBladderCancer adjacent bladder tissue***AT*N
J1010053MBladderCancer adjacent bladder tissue with squamous metaplasia***AT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情